Vascepa vs Lipitor

Listen to the article instead of reading through it.


For patients with high cholesterol levels or other types of lipid disorders, certain drugs that alter the concentrations of lipids in the blood can help in stabilizing cardiovascular risks and managing symptoms. Vascepa and Lipitor are two such drugs that are prescribed for hyperlipidemia. They each impact different aspects of lipid metabolism but both have protective effects on cardiovascular health.

Vascepa is a highly purified form of eicosapentaenoic acid (EPA), one type of omega-3 fatty acid, which is known to reduce triglyceride levels without raising low-density lipoprotein (LDL) cholesterol levels. On the other hand, Lipitor falls under the class called statins and primarily works by inhibiting an enzyme required for producing cholesterol thereby reducing LDL cholesterol levels significantly in your body.

What is Vascepa?

Icosapent ethyl (the generic name for Vascepa) is a type of omega-3 fatty acid, a fat found in fish oil. It is used along with a low-fat and low-cholesterol diet to lower high levels of triglycerides (fats) in adults. This medication works by decreasing the amount of triglycerides made by the body.

On the other hand, Atorvastatin (the generic name for Lipitor) belongs to a group of drugs known as "statins." It was first approved by the FDA in 1996. Lipitor reduces levels of bad cholesterol and triglycerides in the blood while increasing levels of good cholesterol. This action helps prevent heart disease and stroke.

While both medications are designed to improve cardiovascular health, they work differently and have different side effects profiles. Vascepa primarily targets high triglyceride levels without impacting LDL ("bad") cholesterol or causing some common statin side effects such as muscle pain. Conversely, Lipitor effectively lowers LDL cholesterol but may cause certain side effects like headaches, difficulty sleeping, skin flushes, muscle pain or weakness.

What conditions is Vascepa approved to treat?

Vascepa is approved for use in the following conditions:

  • As an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia
  • To reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated triglyceride levels and established cardiovascular disease or diabetes mellitus and two or more additional risk factors for cardiovascular disease.

How does Vascepa help with these illnesses?

Vascepa is used to manage heart disease by increasing the level of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in your blood. It does this by providing a direct supplement of EPA, thus levels can be maintained higher for longer periods of time. Omega-3 fatty acids play an important role in heart health, brain function, and inflammation control among other things. There is evidence that individuals with heart disease have relatively lower levels of omega-3s. Therefore, by increasing EPA through Vascepa supplementation, it may limit the negative impact on cardiovascular health and assist patients in managing their condition more effectively.

On the other hand, Lipitor helps to manage high cholesterol and reduce risk for cardiovascular diseases by blocking a particular enzyme known as HMG-CoA reductase which is involved in the production of cholesterol in liver cells. By inhibiting this enzyme's activity, Lipitor can decrease LDL or "bad" cholesterol and increase HDL or "good" cholesterol thereby helping maintain overall balance of lipids essential for vascular health.

What is Lipitor?

Lipitor is a brand name for atorvastatin, which is a HMG CoA reductase inhibitor or "statin," meaning it works by reducing the levels of "bad" cholesterol (low-density lipoprotein, or LDL) and triglycerides in the blood while increasing levels of "good" cholesterol (high-density lipoprotein, or HDL). It accomplishes this by inhibiting an enzyme in the liver that plays a crucial role in the production of cholesterol. Lipitor was first approved by the FDA in 1996. Unlike Vascepa - which primarily targets high triglyceride levels - Lipitor can help with multiple aspects of lipid control making it versatile for managing different patterns of dyslipidemia. This statin does not exhibit any notable interactions with serotonin and therefore doesn't have side effects like sedation or weight gain often associated with some antidepressants such as Prozac. The benefits on lipid profile can be advantageous for cardiovascular health especially in patients who do not respond well to other types of drugs aimed at improving lipid parameters such as Vascepa.

What conditions is Lipitor approved to treat?

Lipitor is widely recognized and prescribed for the treatment of high cholesterol levels, significantly reducing the risk of coronary heart disease. The indications for Lipitor include:

  • Hypercholesterolemia, a condition characterized by very high levels of cholesterol in the blood
  • Prevention of cardiovascular diseases such as stroke and heart attack in individuals who are at increased risk

How does Lipitor help with these illnesses?

Lipitor, also known as atorvastatin, is a statin medication used to lower cholesterol and triglyceride levels in the blood. It operates by inhibiting HMG-CoA reductase, an enzyme involved in producing cholesterol in the liver. By reducing the formation of cholesterol, Lipitor decreases the amount of low-density lipoprotein (LDL) or "bad" cholesterol and increases high-density lipoprotein (HDL), or "good" cholesterol. This shift helps prevent atherosclerosis and cardiovascular disease like heart attacks and strokes. While Vascepa is primarily used to reduce triglycerides without influencing LDL-C levels significantly, Lipitor acts on both fronts - combating high LDL-C levels while also lowering triglycerides if they are elevated. Its multiple effects make it a more versatile choice for many patients with varying lipid disorders.

How effective are both Vascepa and Lipitor?

Both Vascepa (icosapent ethyl) and Lipitor (atorvastatin) are well-established treatments for reducing cardiovascular risk, but they work in very different ways. Vascepa is a purified form of the omega-3 fatty acid eicosapentaenoic acid (EPA), while Lipitor belongs to the class of drugs known as statins that reduce cholesterol production in the liver.

In a direct comparison study completed in 2019, adding Vascepa to statin therapy was shown to significantly reduce major adverse cardiovascular events compared with a placebo group taking only statins. This suggests that despite both being effective at reducing cardiovascular risk, combining them may offer additional benefits.

A review from 2020 confirmed that Lipitor has been widely used and studied since it came on the market two decades ago due to its high efficacy at lowering LDL ("bad") cholesterol levels. It's typically taken once daily, with an optimal dose usually ranging between 10mg and 80mg depending on individual patient needs and tolerability.

Vascepa received FDA approval more recently in 2012 but has already made significant strides within cardiology circles due to its unique ability among omega-3 fatty acids to lower triglyceride levels without raising bad LDL cholesterol. Its usual recommended dose is 4g per day divided into two equal doses.

While both medications have proven beneficial effects on heart health, each one targets different aspects related to heart disease: Lipitor lowers LDL cholesterol which can clog arteries if left untreated; whereas Vascepa reduces high triglycerides also linked with increased risk of cardiovascular disease. Therefore, these two medications could potentially complement each other when prescribed together under appropriate circumstances.

abstract image of a researcher studying a bottle of drug.

At what dose is Vascepa typically prescribed?

Oral dosages of Vascepa and Lipitor both vary depending on the individual's health status and doctor's recommendations. For Vascepa, typically used for reducing triglyceride levels in adults with severe hypertriglyceridemia, the usual dosage is 4 grams per day taken as 2 capsules twice daily with food. Meanwhile, Lipitor, which is primarily used to lower cholesterol and reduce risk of heart attack or stroke, can range from 10-80 mg/day. Most people are started on a dose between 10-20 mg/day but this can be increased after a few weeks if there isn't sufficient response. The maximum Lipitor dosage that should not be exceeded in any case is 80 mg/day.

Find Top Clinical Trials

Choose from over 30,000 active clinical trials.

At what dose is Lipitor typically prescribed?

Lipitor therapy is typically initiated at a dosage of 10-20 mg/day, taken once daily. The dosage can then be gradually increased to as high as 80 mg/day, based on the patient's LDL cholesterol levels and overall response to treatment. Lipitor should be taken at any time of day, with or without food. It is crucial that patients continue taking Lipitor even if they feel well since high cholesterol levels may not cause any symptoms. If there is no adequate response after several weeks of treatment at the maximum dose, additional or alternative treatments might need consideration.

What are the most common side effects for Vascepa?

Common side effects of Vascepa, a prescription fish oil supplement, include:

  • Joint pain
  • Sore throat (pharyngitis)
  • Risk of bleeding episodes
  • Changes in taste sensation

On the other hand, Lipitor, an HMG-CoA reductase inhibitor or statin used for lowering cholesterol, may cause:

  • Diarrhea
  • Upset stomach (dyspepsia)
  • Muscle and joint pain
  • Alterations in liver function tests
  • Nausea
  • Headache

It's worth noting that both medications have different mechanisms of action and are used to treat different conditions. Therefore their side effect profiles will differ accordingly. Always consult your healthcare provider before starting any new medication.

abstract image of a patient experiencing side effect

Are there any potential serious side effects for Vascepa?

While Vascepa is generally considered safe, it's important to be aware of potential side effects that could indicate a serious reaction. These may include:

  • Signs of an allergic reaction such as hives; difficulty breathing; swelling in your face, lips, tongue, or throat
  • Irregular heart rhythm
  • Shortness of breath
  • Swelling in the hands or feet (fluid retention)
  • Joint pain

As for Lipitor - one should be mindful about these severe reactions:

  • Muscle weakness, tenderness, or pain accompanied by fever or flu-like symptoms
  • Liver problems: upper stomach discomfort/pain, loss of appetite followed by dark urine and yellowing eyes/skin (jaundice)
  • Kidney problems: little to no urinating; painful or difficult urination; swelling in your feet or ankles -Unusual tiredness and weakness

In case any of these signs occur while taking either Vascepa or Lipitor - stop using the medication immediately and seek medical attention.

What are the most common side effects for Lipitor?

Lipitor, a commonly prescribed cholesterol-lowering drug, can have the following side effects:

  • Upset stomach or nausea
  • Diarrhea or constipation
  • Muscle and joint pain
  • Increased blood sugar levels
  • Headache or dizziness
  • Rash on the skin
  • Sleep problems (insomnia)
    Additionally, although rare, Lipitor may also cause liver problems which could lead to loss of appetite. In some cases it might induce confusion or agitation. As with all medications, it's important to discuss potential side effects with your healthcare provider before starting Lipitor.

Are there any potential serious side effects for Lipitor?

In some cases, Lipitor can cause serious side effects. Be on the lookout for:

  • Signs of an allergic reaction such as hives, difficulty breathing or swallowing, and swelling in your face or throat
  • Unusual muscle pain or weakness that could signal a life-threatening muscle problem
  • Dark colored urine, fatigue or jaundice which might indicate liver problems
  • Increased blood sugar levels (symptoms include increased thirst/urination)
  • Severe nausea/vomiting, fever and extraordinary abdominal discomfort as these may be signs of pancreatitis
  • Stroke-like symptoms including sudden numbness/weakness especially on one side of the body.

Remember to seek medical attention immediately if you experience any of these severe reactions while using Lipitor.

Contraindications for Vascepa and Lipitor?

Both Vascepa and Lipitor, like most medications used for lowering cholesterol and triglycerides, may cause muscle pain or weakness in some patients. If you notice worsening of these symptoms or any signs of liver problems such as yellowing eyes/skin, dark urine, severe stomach/abdominal pain, persistent nausea/vomiting or unexplained fatigue please seek immediate medical attention.

Neither Vascepa nor Lipitor should be taken if you are taking certain drugs such as strong CYP3A4 inhibitors (like ketoconazole) or have been prescribed fibrates other than fenofibrate. It's crucial to inform your physician about all the medications you're currently taking; certain drugs could interact negatively with Vascepa and Lipitor. Also remember that consumption of grapefruit juice is not recommended while on a course of treatment involving Lipitor due to potential drug interactions.

How much do Vascepa and Lipitor cost?

In the realm of branded cholesterol medications:

  • The price for 120 capsules (a one month supply) of Vascepa (1 g) averages around $340, which works out to approximately $11/day.
  • Lipitor (20 mg), on the other hand, costs about $450 for a pack of 30 tablets. This translates to roughly $15 per day.

Consequently, if you are taking these drugs at their typical dosages, Vascepa is less expensive than Lipitor on a per-day treatment basis. However, remember that cost should not be your primary consideration in determining which medication is right for you.

As for their generic counterparts:

  • Icosapent ethyl—the generic version of Vascepa—costs substantially less than its brand name counterpart. You can expect to pay between $2 and $5 per day depending on where it's purchased.
  • Atorvastatin —the equivalent generic form of Lipitor—is also much cheaper with prices typically ranging from about $.30-$2 per day depending upon the dosage and location where it's purchased.

Both generics offer significant savings over their branded versions while providing the same effectiveness.

Popularity of Vascepa and Lipitor

Icosapent ethyl, sold under the brand name Vascepa among others, is a medication used to treat cardiovascular disease and high levels of triglycerides. It was estimated to have been prescribed to about 600,000 people in the US in 2020. Icosapent ethyl accounted for just over 2% of all prescriptions for lipid-regulating drugs in the US. However, it appears to be one of the most-common “atypical” lipid-lowering agents (not classified as statins or other broad classes). The prevalence of Icosapent ethyl has been generally increasing since its approval by FDA in 2012.

Atorvastatin calcium, including brand versions such as Lipitor, was prescribed to about 94 million people in the USA during that same period. In terms of prescription numbers alone atorvastatin accounts for more than half of statin prescriptions and nearly a quarter overall cholesterol management drug prescriptions. The prevalence of atorvastatin has remained roughly stable over recent years.


Vascepa (icosapent ethyl) and Lipitor (atorvastatin) both have strong reputations for their effectiveness in managing high cholesterol levels, with numerous clinical trials demonstrating their superiority over placebo. These medications can be used independently or in combination, depending on a physician's evaluation of the patient's overall health status and needs. Their mechanisms of action are distinct; Vascepa is primarily a purified form of omega-3 fatty acid that works by reducing triglyceride levels, while Lipitor hinders cholesterol production in the liver.

Both medications have generic versions available, offering cost-effective options particularly beneficial to those paying out-of-pocket. The onset period may vary between individuals as metabolic responses differ.

The side effect profiles for Vascepa and Lipitor show some commonalities but also key differences. Both are generally well-tolerated but they carry risks such as gastrointestinal discomforts. However, Lipitor has been associated with potential muscle pain or weakness which necessitates regular monitoring by healthcare professionals during treatment initiation or dose adjustment phases. On the other hand, Vascepa does not typically cause these muscular issues making it an excellent alternative for patients who experience this particular side effect from statin therapy like Lipitor.